cd4+ t-cell-depleted haploidentical hematopoietic cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2018 (NCT03249831)
Timeline
Indications
Mechanism of action
- LymphocytesSupplementation
supplementation - lymphocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04201210 | Phase 2 | Apr 1, 2020 | University of Regensburg |
| NCT03249831 | Phase 1 | Sep 30, 2018 | California Institute for Regenerative Medicine, City of Hope National Medical Center |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute for Regenerative Medicine | Academic/Hospital | 1 | 0 | 1 | 2018 |
| City of Hope National Medical Center | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Regensburg | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1